How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack

    Closed for comments This consultation ended on at   Request commenting lead permission

    5 Review

    NICE will regularly monitor its published technology guidance to check for any new evidence or information that could affect the recommendations. Guidance will not have a fixed review date.

    Brian Shine

    Chair, diagnostics advisory committee

    March 2024